Generic versions of common epilepsy, bipolar drug to be released soon

07/30/2008 | Bloomberg

Eight drug manufacturers have been approved to market a generic version of Depakote DR, a delayed-release treatment for epilepsy, bipolar disorder and migraines. The generic treatments will have the same safety label as the brand-name version, including a warning about the risk of death from liver injury or pancreas inflammation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Content Design Manager, Science
NWEA
Multiple Locations, SL_Multiple Locations
Math Specialist
PCG Education
Richmond, VA
Sr. Technical Product Manager
NWEA
Portland, OR
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Production Manager, Education and Leadership
Asia Society
New York, NY